This hub covers status epilepticus, a seizure emergency, which is when a seizure doesn’t stop or seizures happen back-to-back without recovery. The 5-minute rule, rescue meds, and what care looks like.
A convulsive seizure approaching 5 minutes is treated seriously because the chance it won’t stop rises.
If a convulsive seizure lasts ~5 minutes, breathing is abnormal, injury occurs, it’s a first seizure, or recovery is not typical.
Yes. Confusion, staring, or unusual behavior that doesn’t resolve can be nonconvulsive status, especially in hospital settings.
Not always. Some families have plans that include rescue meds and monitoring. But prolonged convulsive seizures generally need urgent care.
Researchers studied a group of 60 patients with epilepsy characterized by myoclonic-atonic seizures, a type of seizure that can cause sudden falls and loss of muscle control.
This study looked at a rare complication called Horner syndrome that can occur after vagus nerve stimulation (VNS) surgery, which is a treatment for epilepsy that doesn’t respond to medication.
Researchers studied a 5-year-and-11-month-old boy who developed a severe form of epilepsy called febrile infection-related epilepsy syndrome (FIRES) after a fever.
This study looked at five adults with Febrile Infection-Related Epilepsy Syndrome (FIRES), a serious condition that causes severe seizures after a fever.
Researchers studied two specific types of epilepsy syndromes called New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) in children.
This study looked at a specific brain imaging sign called the symmetrical claustrum sign (SCS) in children diagnosed with febrile infection-related epilepsy syndrome (FIRES).
This study looked at how two treatments, vagus nerve stimulation (VNS) and epilepsy surgery (ES), affect the use of seizure medications in children with drug-resistant epilepsy (DRE).
This study focuses on the use of vagus nerve stimulation (VNS) as a treatment for status epilepticus in children, which is a serious condition where seizures last too long or happen back-to-back.
The STIRUS study looked at how effective stiripentol, a medication approved for Dravet syndrome (DS), is for patients in the United States.